Search

everythinglearnresearchcommunity

for

Search:↓

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

A patient lost all their hair while on rheumatoid arthritis medication.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Cannabinoids may help some skin conditions but more research is needed.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

About one-third of dermatology patients in Ankara, Turkey use unconventional treatments for skin issues.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.